Green Thumb Industries 2025 results and profitability
Green Thumb’s 2025 financial performance tells a powerful story for cannabis investors. The company reported $311.1 million in fourth quarter revenue and $1.2 billion for the year. Because gross margins and normalized EBITDA strengthened, the results matter beyond top line growth. Those gains suggest stronger operational efficiency and disciplined capital allocation.
In addition, share repurchases and a larger credit facility increased balance sheet flexibility. However, price compression and regulatory uncertainty still temper the near term outlook. Therefore this piece will unpack revenue drivers, margin trends, cash flow, and capital spend. Expect clear takeaways for CPG cannabis brands and investors as we move from Q4 details to full year analysis.
We will highlight retail expansion, brand leadership, and 2026 capital plans. By the end, readers will understand what Green Thumb’s momentum means for market positioning and profitability prospects. This analysis will help executives, investors, and CPG partners plan next steps. Let’s dive in.
Green Thumb Industries 2025 results and profitability: Financial snapshot
Green Thumb reported strong top line growth and improving margin metrics in 2025. The numbers reveal how revenue expansion, operational efficiency, and disciplined capital allocation drove profitability. Below are the key financial highlights and what they mean for investors and CPG partners.
Key metrics
- Q4 2025 total revenue: $311.1 million, up 5.7% year over year. Source
- Full year 2025 total revenue: $1.2 billion, up 3.4% from 2024. Source
- Q4 2025 gross profit: $141.3 million, or 45.4% of revenue. Full year gross profit: $574.9 million, or 48.9% of revenue.
- Q4 2025 EBITDA: $75.3 million, or 24.2% of revenue. Normalized Q4 EBITDA: $100.2 million, or 32.2% of revenue.
- Normalized EBITDA full year 2025: $348.4 million, or 29.6% of revenue.
- Net income before noncontrolling interest: Q4 $83.1 million; full year $116.1 million. These gains reflect stronger core profitability.
- Cash and equivalents at 12/31/2025: $274.3 million. Total debt: $244.9 million, including $142.5 million senior debt. Credit facility increased by $50 million; principal outstanding $189 million.
- Cash flow from operations in 2025: $295 million. Share repurchases since September 2023: ~15.5 million shares for $121.8 million.
What this means
Margins held up despite price compression, which shows operational leverage. Therefore the company converted more revenue into cash.
In addition, retail expansion and brand leadership supported volume gains. For third party context on brand strength, see BDSA coverage summarized here.
For investor perspective on how these results fit broader market trends, consult these resources: CBD Advisor 2026 outlook and Cannabis Stock Investing 2026.
Overall, Green Thumb’s 2025 results show resilient profitability and a fortified balance sheet. As a result, the company enters 2026 with both cash and strategic flexibility to pursue growth.
Market impact: Green Thumb Industries 2025 results and profitability
Green Thumb’s 2025 results cement its scale advantage and operating leverage. The company posted $1.2 billion in revenue and normalized EBITDA of $348.4 million. Cash from operations reached $295 million, and cash on hand was $274.3 million. Therefore the firm enters 2026 with significant financial flexibility.
Competitive advantages and brand leadership
- National brand leadership: RYTHM ranked No.1 flower brand per BDSA, with Animal Face the top selling unit.
- Retail footprint: expanded to 113 stores across 14 states, enabling distribution and margin control.
- Margin resilience: full year gross profit $574.9 million and gross margin near 49%, showing efficiency.
- Capital allocation: repurchased about 15.5 million shares for $121.8 million and increased credit capacity by $50 million.
Challenges, price compression, and regulatory risk
However, price compression persists and pressures unit economics. Total debt stood at $244.9 million while principal outstanding on the credit facility was $189 million. Capex guidance for 2026 sits near $80 million, which will absorb cash. As a result, management must balance growth and shareholder returns to maintain competitive position.
Additionally, the Minnesota adult-use transition boosted fourth quarter sales. Eight RISE Dispensaries converted in September 2025 and added meaningful adult-use volume. Therefore the regional playbook could scale to other states as reform advances. However, federal reform remains uncertain and can limit national expansion.
| Company | 2025 Revenue | 2025 Net Income (Loss) | Profit Margin (reported) | YoY Revenue Growth |
|---|---|---|---|---|
| Green Thumb Industries | $1.20 billion | $116.1 million (net income before noncontrolling interest) | Gross margin 48.9% | +3.4% |
| Curaleaf Holdings | $1.27 billion | Net loss $201.9 million | Gross margin ~50% | — |
| Trulieve Cannabis Corp. | $1.20 billion | Net loss $116 million (reported) | Gross margin ~60% | — |
| Canopy Growth Corporation | $269.0 million | Reported net loss; adjusted EBITDA loss improved ~$23.5 million | Gross margin ~30% | — |
Sources
- Green Thumb Industries 2025 results press release
- Curaleaf 2025 results press release
- Trulieve 2025 results press release
- Canopy Growth 2025 financial results
Notes
- Blank growth fields indicate companies did not highlight a simple year-over-year revenue percentage in the cited release. Where available, profit margin uses reported gross margin or adjusted gross margin from each company release.
Conclusion
Green Thumb’s 2025 results and profitability reinforce market resilience and strategic momentum. The company delivered $1.2 billion in revenue and strong normalized EBITDA. Because margins remained near 49%, Green Thumb converted revenue into cash efficiently. Cash flow from operations reached $295 million, providing growth capital and flexibility.
In addition, retail expansion to 113 stores boosted distribution and brand reach. However, price compression and regulatory uncertainty remain real challenges. Therefore management must balance capex, debt, and shareholder returns. EMP0 emerges as a relevant collaborator and industry factor to watch.
For timely analysis and investor guidance, visit MyCBDAdvisor. The company’s brand leadership with RYTHM and other labels strengthens long term prospects. Moreover, disciplined capital allocation and share repurchases signal management confidence. As a result, investors and CPG partners should watch execution on margins and expansion. MyCBDAdvisor will continue to track developments. MyCBDAdvisor will provide timely, reliable analysis.
Frequently Asked Questions (FAQs)
What do the Green Thumb Industries 2025 results and profitability show?
Green Thumb reported $1.2 billion in full year revenue and $311.1 million in Q4 revenue. Normalized EBITDA for 2025 reached $348.4 million. Full year gross profit was $574.9 million, about 48.9% of revenue. Cash flow from operations totaled $295 million, and cash on hand was $274.3 million.
Did Green Thumb record net income in 2025?
Yes. Net income before noncontrolling interest was $116.1 million for the full year. Q4 net income before noncontrolling interest was $83.1 million. However, investors should compare GAAP and non GAAP metrics for a full picture.
What drove the companys profitability in 2025?
Profitability rose because of stronger gross margins and operational efficiency. Brand leadership from RYTHM and retail expansion to 113 stores boosted volume. In addition, disciplined capital allocation, including share buybacks, improved returns.
What risks could pressure future profitability?
Price compression remains a headwind and can compress margins. Regulatory uncertainty at the federal level could slow expansion. Also, planned 2026 capex of about $80 million will consume cash.
What should investors and CPG partners watch now?
Watch margin trends, cash flow conversion, and execution on store growth. In addition, monitor debt levels and capital allocation. These factors will determine whether the 2025 momentum sustains.
